Welcome to Fierce Pharma’s 2024 regulatory tracker. We’re keeping track of the approval progress for pharmaceutical products, including their expansion […]

At a conference in New England, Rohan Simon, the associate director of a UAE-based contract research organization, spoke about the […]

LAMA2-CMD is a serious muscle disease caused by a missing protein called LAMA2, leading to early muscle weakness. The FDA […]

Ultra-processed foods (UPFs) in India are being linked to health issues like obesity, diabetes, heart disease, and some cancers. In […]

AbbVie, a pharmaceutical company, is buying Aliada Therapeutics for $1.4 billion. This purchase includes Aliada’s main experimental drug, ALIA-1758, which […]

A recent trial showed that nearly 60% of patients using Fasenra reached remission. The European Commission has approved Fasenra, a […]

At a conference on clinical trials in New England, the U.S. Customs and Border Protection (CBP) warned researchers about common […]

The MVA-BN vaccine, known as Jynneos in the US and Imvanex in Europe, is being tested to see if it […]

The US regulator is currently assessing an additional application for VTAMA cream to treat atopic dermatitis. Organon recently acquired Dermavant […]